An evaluation of analysis pipelines for DNA methylation profiling using the illumina humanmethylation450 BeadChip platform

Epigenetics

Volumn 8, Issue 3, 2013, Pages 333-346

  Marabita, Francesco ^a   Almgren, Malin ^a   Lindholm, Maléne E ^a   Ruhrmann, Sabrina ^a   Fagerström Billai, Fredrik ^a   Jagodic, Maja ^a   Sundberg, Carl J ^a   Ekström, Tomas J ^a   Teschendorff, Andrew E ^b   Tegnér, Jesper ^a   Gomez Cabrero, David ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Bioinformatics Infrastructure for Life Sciences (BILS)   (Sweden)

Author keywords

DNA methylation; Illumina 450K; Microarray; Normalization; Technical variability

Indexed keywords

CD14 ANTIGEN; DEOXYRIBONUCLEASE;

ARTICLE; BIOINFORMATICS; CELL STRAIN HCT116; CONTROLLED STUDY; CPG ISLAND; DNA FINGERPRINTING; DNA METHYLATION; HUMAN; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; MONOCYTE; MULTIDIMENSIONAL SCALING; NUCLEOTIDE SEQUENCE; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

EID: 84875737335     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.24008     Document Type: Article

References (41)

1. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011; 12:529-41; PMID:21747404; http://dx.doi.org/10.1038/nrg3000.
2. Feinberg AP. Epigenomics reveals a functional genome anatomy and a new approach to common disease. Nat Biotechnol 2010; 28:1049-52; PMID:20944596; http://dx.doi.org/10.1038/nbt1010-1049.
3. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010; 465:721-7; PMID:20535201; http://dx.doi.org/10.1038/nature09230.
4. Lan X, Adams C, Landers M, Dudas M, Krissinger D, Marnellos G, et al. High resolution detection and analysis of CpG dinucleotides methylation using MBD-Seq technology. PLoS One 2011; 6:e22226; PMID:21779396; http://dx.doi.org/10.1371/journal.pone.0022226.
5. Serre D, Lee BH, Ting AH. MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res 2010; 38:391-9; PMID:19906696; http://dx.doi.org/10.1093/nar/gkp992.
6. Borgel J, Guibert S, Weber M. Methylated DNA immunoprecipitation (MeDIP) from low amounts of cells. Methods Mol Biol 2012; 925:149-58; PMID:22907495; http://dx.doi.org/10.1007/978-1-62703-011-3_9.
7. Mohn F, Weber M, Schübeler D, Roloff TC. Methylated DNA immunoprecipitation (MeDIP). Methods Mol Biol 2009; 507:55-64; PMID:18987806; http://dx.doi.org/10.1007/978-1-59745-522-0_5.
8. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315-22; PMID:19829295; http://dx.doi.org/10.1038/nature08514.
9. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454:766-70; PMID:18600261.
10. Irizarry RA, Ladd-Acosta C, Carvalho B, Wu H, Brandenburg SA, Jeddeloh JA, et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res 2008; 18:780-90; PMID:18316654; http://dx.doi.org/10.1101/gr.7301508.
11. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 2010; 28:1097-105; PMID:20852635; http://dx.doi.org/10.1038/nbt.1682.
12. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98:288-95; PMID:21839163; http://dx.doi.org/10.1016/j.ygeno.2011.07.007.
13. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, et al. Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 2009; 1:177-200; PMID:22122642; http://dx.doi.org/10.2217/epi.09.14.
14. Sandoval J, Heyn HA, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692-702; PMID:21593595; http://dx.doi.org/10.4161/epi.6.6.16196.
15. Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F. Evaluation of the Infinium Methylation 450K technology. Epigenomics 2011; 3:771-84; PMID:22126295; http://dx.doi.org/10.2217/epi.11.105.
16. Maksimovic J, Gordon L, Oshlack A. SWAN: Subset-quantile within array normalization for illumine infinium HumanMethylation450 BeadChips. Genome Biol 2012; 13:R44; PMID:22703947; http://dx.doi.org/10.1186/gb-2012-13-6-r44.
17. Touleimat N, Tost J. Complete pipeline for Infinium(®) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 2012; 4:325-41; PMID:22690668; http://dx.doi.org/10.2217/epi.12.21.
18. Teschendorff AE, Marabita F, Lechner M, Bartlett T, TegnEr J, Gomez-Cabrero D, et al. A Beta-Mixture Quantile Normalisation method for correcting probe design bias in Illumina Infinium 450k DNA methylation data. Bioinformatics 2013; 29:189-96; PMID: 23175756; http://dx.doi.org/10.1093/bioinformatics/bts680
19. Jaffe AE, Murakami P, Lee H, Leek JT, Fallin MD, Feinberg AP, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol 2012; 41:200-9; PMID:22422453; http://dx.doi.org/10.1093/ije/dyr238.
20. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, et al. Differential DNA meth-ylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7:e41361; PMID:22848472; http://dx.doi.org/10.1371/journal.pone.0041361.
21. Sun Z, Chai HS, Wu Y, White WM, Donkena KV, Klein CJ, et al. Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med Genomics 2011; 4:84; PMID:22171553; http://dx.doi.org/10.1186/1755-8794-4-84.
22. Qu Y, Tan M, Kutner MH. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics 1996; 52:797-810; PMID:8805757; http://dx.doi.org/10.2307/2533043.
23. Hui SL, Zhou XH. Evaluation of diagnostic tests without gold standards. Stat Methods Med Res 1998; 7:354-70; PMID:9871952; http://dx.doi.org/10.1191/096228098671192352.
24. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010; 11:587; PMID:21118553; http://dx.doi.org/10.1186/1471-2105-11-587.
25. Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, Edinger M, et al. Lineage-specific DNA meth-ylation in T cells correlates with histone methylation and enhancer activity. Genome Res 2009; 19:1165-74; PMID:19494038; http://dx.doi.org/10.1101/gr.091470.109.
26. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473:43-9; PMID:21441907; http://dx.doi.org/10.1038/nature09906.
27. Illingworth RS, Bird AP. CpG islands--'a rough guide'. FEBS Lett 2009; 583:1713-20; PMID:19376112; http://dx.doi.org/10.1016/j.febslet.2009.04.012.
28. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13:484-92; PMID:22641018; http://dx.doi.org/10.1038/nrg3230.
29. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178-86; PMID:19151715; http://dx.doi.org/10.1038/ng.298.
30. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, et al. Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009; 41:1350-3; PMID:19881528; http://dx.doi.org/10.1038/ng.471.
31. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, et al. Increased meth-ylation variation in epigenetic domains across cancer types. Nat Genet 2011; 43:768-75; PMID:21706001; http://dx.doi.org/10.1038/ng.865.
32. rd, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990; 249:1288-90; PMID:1697983; http://dx.doi.org/10.1126/science.1697983.
33. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363:2424-33; PMID:21067377; http://dx.doi.org/10.1056/NEJMoa1005143.
34. Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012; 483:479-83; PMID:22343889; http://dx.doi.org/10.1038/nature10866.
35. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012; 150:12-27; PMID:22770212; http://dx.doi.org/10.1016/j.cell.2012.06.013.
36. Heichman KA, Warren JD. DNA methylation biomarkers and their utility for solid cancer diagnostics. Clin Chem Lab Med 2012; 50:1707-21; PMID:23089699; http://dx.doi.org/10.1515/cclm-2011-0935.
37. Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679-92; PMID:22945394; http://dx.doi.org/10.1038/nrg3270.
38. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 2010; 11:191-203; PMID:20125086; http://dx.doi.org/10.1038/nrg2732.
39. Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 2007; 3:1724-35; PMID:17907809; http://dx.doi.org/10.1371/journal.pgen.0030161.
40. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24:1547-8; PMID:18467348; http://dx.doi.org/10.1093/bioinformatics/btn224.
41. Beath K. randomLCA: Random Effects Latent Class Analysis. 2011. http://CRAN.R-project.org/package=randomLCA